TY  - GEN
AU  - Currier,J S
AU  - Williams,P L
AU  - Koletar,S L
AU  - Cohn,S E
AU  - Murphy,R L
AU  - Heald,A E
AU  - Hafner,R
AU  - Bassily,E L
AU  - Lederman,H M
AU  - Knirsch,C
AU  - Benson,C A
AU  - Valdez,H
AU  - Aberg,J A
AU  - McCutchan,J A
TI  - Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team
SN  - 0003-4819
PY  - 2000///1005
KW  - AIDS-Related Opportunistic Infections
KW  - prevention & control
KW  - Adult
KW  - Anti-Bacterial Agents
KW  - adverse effects
KW  - Anti-HIV Agents
KW  - therapeutic use
KW  - Azithromycin
KW  - CD4 Lymphocyte Count
KW  - Disease Progression
KW  - Double-Blind Method
KW  - Female
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - genetics
KW  - Humans
KW  - Immunocompromised Host
KW  - Male
KW  - Mycobacterium avium Complex
KW  - Mycobacterium avium-intracellulare Infection
KW  - Placebos
KW  - Proportional Hazards Models
KW  - RNA, Viral
KW  - blood
KW  - Viral Load
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.7326/0003-4819-133-7-200010030-00008
ER  -